Patients with MACE [n = 106, (39.8%)] | Patients without MACE [n = 160, (60.2%)] | (P value)* | |
---|---|---|---|
Mean (SD) | Mean (SD) | ||
RVBD | 3.42 (0.47) | 3.41 (0.44) | 0.88 |
RVLD | 7.82 (0.23) | 7.82 (0.23) | 0.89 |
WMSI | 7.16 (3.18) | 6.68 (2.64) | 0.19 |
Mitral E/A ratio | 0.98 (0.34) | 1.02 (0.35) | 0.49 |
Mitral E/e′ ratio | 11.32 (4.23) | 11.28 (3.18) | 0.92 |
LVEF% | 38.03 (2.95) | 40.09 (3.68) | 0.001* |
LAVI | 28.11 (2.02) | 27.64 (1.73) | 0.042* |
Tricuspid E/A ratio | 1.07 (0.34) | 1.05 (0.36) | 0.67 |
Tricuspid E/e′ ratio | 6.73 (2.45) | 6.44 (1.95) | 0.29 |
S’ wave PTSV (cm/s) | 10.18 (1.79) | 11.39 (2.17) | 0.001* |
TAPSE | 1.52 (0.13) | 1.70 (0.17) | 0.001* |
RVFAC% | 36.41 (2.17) | 39.27 (2.97) | 0.001* |
LV ESd (mm) | 29.56 (2.27) | 29.03 (2.20) | 0.06 |
LV EDd (mm) | 48.58 (2.05) | 48.65 (2.08) | 0.79 |
LV EDV (ml) | 147.29 (12.44) | 144.43 (11.86) | 0.06 |
LV ESV (ml) | 46.66 (6.34) | 44.57 (6.33) | 0.009* |